ANTIBODY ANALYTICS LIMITED Financials
- Company number
- SC520998Copy
Copy - Registered office
- Rouken Discovery Centre, Braidhurst Industrial Estate, Motherwell, North Lanarkshire ML1 3ST
- Incorporated
- 24/11/2015
Company snapshot
- Status
- Active
- Employees
- 1 (2025)
- Latest financial data
- 2025
- Accounts type
- Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
61.53%vs 20242024: £2.43M
Total Assets
11.77%vs 20242024: £15.59M
Cash in Bank
-16.71%vs 20242024: £3.01M
Total Liabilities
-3.75%vs 20242024: £9.34M
Employees
0vs 20242024: 1
In 2025, ANTIBODY ANALYTICS LIMITED reported net assets of £3.93M. The same filing shows total assets of £17.42M, cash in bank of £2.50M and total liabilities of £8.99M. Reported headcount was 1 in 2025. Total Assets rose from £15.59M in 2024 to £17.42M in 2025 (11.77%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
61.53%from £2.43M in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures ANTIBODY ANALYTICS LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
+26.5%vs 2023+12.5% a year compound (CAGR)
Cash in Bank
-60.1%vs 2023-36.8% a year compound (CAGR)
Total Assets
+28.8%vs 2023+13.5% a year compound (CAGR)
Total Liabilities
+9.1%vs 2023+4.4% a year compound (CAGR)
Employees
-98.8%vs 2023-83Biggest increase
Total Assets+28.8%
£13.52M in 2023 to £17.42M in 2025
Biggest decrease
Employees-98.8%
84 in 2023 to 1 in 2025
ANTIBODY ANALYTICS LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in total assets, pointing to a broader asset base, set against a fall in employee numbers, pointing to a smaller workforce. See the full year-by-year figures.
Ratios from the filed figures
Calculated from ANTIBODY ANALYTICS LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 22.56%2025
- Liabilities to total assets
- 51.61%2025
- Cash to liabilities
- 27.84%2025
- Cash to total assets
- 14.37%2025
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for ANTIBODY ANALYTICS LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 846.16K | 767.51K | 3.11M | 2.43M | 3.93M |
| Total Assets£ | 4.33M | 5.35M | 13.52M | 15.59M | 17.42M |
| Cash in Bank£ | 842.56K | 913.28K | 6.27M | 3.01M | 2.50M |
| Total Liabilities£ | 2.08M | 2.72M | 8.24M | 9.34M | 8.99M |
| Employees | 60 | 64 | 84 | 1 | 1 |
ANTIBODY ANALYTICS LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Has ANTIBODY ANALYTICS LIMITED filed financial statements?
Yes. Okredo holds filed figures for ANTIBODY ANALYTICS LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
What net assets did ANTIBODY ANALYTICS LIMITED report in 2025?
ANTIBODY ANALYTICS LIMITED reported net assets of £3.93M for 2025. That compares with £2.43M in 2024, a change of 61.53%.
What total assets did ANTIBODY ANALYTICS LIMITED report in 2025?
ANTIBODY ANALYTICS LIMITED reported total assets of £17.42M for 2025. That compares with £15.59M in 2024, a change of 11.77%.
What cash in bank did ANTIBODY ANALYTICS LIMITED report in 2025?
ANTIBODY ANALYTICS LIMITED reported cash in bank of £2.50M for 2025. That compares with £3.01M in 2024, a change of -16.71%.
How many people does ANTIBODY ANALYTICS LIMITED employ?
ANTIBODY ANALYTICS LIMITED reported 1 employee in 2025, compared with 1 in 2024.
How have ANTIBODY ANALYTICS LIMITED financials changed over the last 3 years?
Between 2023 and 2025, ANTIBODY ANALYTICS LIMITED's net assets rose by 26.5%, cash in bank fell by 60.1%, total assets rose by 28.8% and total liabilities rose by 9.1%. Net assets compounded at 12.5% a year across the two years to 2025, from £3.11M to £3.93M. Reported headcount went from 84 in 2023 to 1 in 2025 (-83).
Which years of ANTIBODY ANALYTICS LIMITED financial data are available?
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.